Lower Your Risk with Early Detection

Today’s prostate landscape is changing in terms of both detection and available treatment options.

With the help of the prostate specific antigen (PSA) blood test and the digital rectal exam (DRE), there is a dramatic increase in early identification of prostate cancer, often at a lower risk and earlier stage. In fact, 75% of prostate cancer is currently diagnosed when the disease is still contained inside the prostate gland1. 35% of prostate cancer is diagnosed in men before the age of 65, and over 72% is found before a man turns age 75.

In response to this trend there are a number of new options to treat and/or manage prostate tumors. Less invasive treatment methods are emerging that are better able to reduce or eliminate side effects

Not every patient is comfortable with the idea of delaying treatment while monitoring for possible disease progression. Thus, after thorough diagnosis, patients may turn to targeted treatment options focused on ablating (destroying) the known tumor(s) while sparing the remaining healthy prostate tissue2. For patients whose best option is whole-gland treatment, options include radical prostatectomy using robotics for a less invasive approach (Robotic Prostatectomy) and a range of new High Definition Radiation Therapies.

As a result of the changing prostate landscape, patients want and need clear, reliable information. This information will help the patient and their doctors make an accurate diagnosis and treatment plan.

The Sperling Prostate Center uses a comprehensive detection protocol to create a detailed prostate map that provides precise information about the size, location and shape of any potential prostate tumors – all critical information for guiding a biopsy and/or choosing a treatment. Using leading-edge MRI (magnetic resonance imaging) technology, the Sperling team can detect potential tiny tumors within the prostate. This detection offers vital information that can help patients and doctors defer, alter or more accurately direct their diagnosis, treatment and follow up.